These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. Management of functional bowel disorders: double-blind evaluation of Cantil and Cantate. Hock CW Med Times; 1968 Oct; 96(10):997-1003. PubMed ID: 4878497 [No Abstract] [Full Text] [Related]
87. Influence of emylcamate, meprobamate, and placebo on psychologic test performance. JONSSON CO; ANDERSEN K Clin Pharmacol Ther; 1960; 1():708-15. PubMed ID: 13790642 [No Abstract] [Full Text] [Related]
88. Combined pharmacotherapy and psychotherapy. Uhlenhuth EH; Lipman RS; Covi L J Nerv Ment Dis; 1969 Jan; 148(1):52-64. PubMed ID: 4388798 [No Abstract] [Full Text] [Related]
89. Blind study of an artane-like antispasmodic with and without the addition of a tranquilizing agent or a second antispasmodic. BAUER HG; McGAVACK TH N Y State J Med; 1958 Jul; 58(14):2375-80. PubMed ID: 13566512 [No Abstract] [Full Text] [Related]
91. A comparative clinical study of meprobamate and chlordiazepoxide. PENNINGTON VM Med Times; 1962 Aug; 90():841-6. PubMed ID: 14485129 [No Abstract] [Full Text] [Related]
92. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590 [TBL] [Abstract][Full Text] [Related]
93. [STUDY OF THE HYPNOTIC POWER OF A NEW THERAPEUTIC COMBINATION: MEPROBAMATE-CB 1664]. LEBLOIS J Lille Med; 1964 Jan; 9():88-9. PubMed ID: 14124119 [No Abstract] [Full Text] [Related]
94. [Therapeutic study of the combination of meprobamate with current neuroleptics]. DUC N; MONNIER A; BERGONIER J Rev Med Fr; 1960 Apr; 41():299-301. PubMed ID: 24546482 [No Abstract] [Full Text] [Related]
95. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate). SELLING LS J Am Med Assoc; 1955 Apr; 157(18):1594-6. PubMed ID: 14367012 [No Abstract] [Full Text] [Related]
96. [Effect of meprobamate and emylcamate on human performance in a prolonged serial task]. BERTELSON P; JOFFE R Psychopharmacologia; 1962 Oct; 3():242-53. PubMed ID: 13966735 [No Abstract] [Full Text] [Related]
97. Hypersensitivity following ingestion of hydroxyzine (atarax) in a meprobamate-sensitive patient. COHEN AE; COHEN NK J Allergy; 1958; 29(6):542-4. PubMed ID: 13587125 [No Abstract] [Full Text] [Related]
98. An evaluation of meprobamate in the management of selected dermatosis. BECKER FT; FREDRICKS MG; SCHMID JF; TUURA JL AMA Arch Derm; 1958 Apr; 77(4):406-9; discussion 409-11. PubMed ID: 13519839 [No Abstract] [Full Text] [Related]
99. [Meprobamate in psychiatric practice]. BOHN L; ELKJAER P; LASSENIUS B; OSTERMAN E Sven Lakartidn; 1956 Oct; 53(42):2689-98. PubMed ID: 13380763 [No Abstract] [Full Text] [Related]
100. Tranquillizers in mental deficiency: meprobamate. CRAFT M J Ment Defic Res; 1958 Jun; 2(1):17-20. PubMed ID: 13576049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]